With multiple indications from MASH to OSA- this study represents the tip of the efficacy (figurative) iceberg -these drugs are bound to change how obesity and related conditions are managed.
Over time, this chronic inflammation damages the thyroid, leading to hypothyroidismor underactive thyroid function
Prioritising a nutrient-dense protocol helps counteract this effect by strengthening the skins structural scaffolding
Ania Jastreboff, an obesity medicine physician scientist at Yale University School of Medicine/Yale School of Medicine, co-Director of the Yale Center for Weight Management and the lead author on the phase 2 study, said that the results were striking and concluded that Retatrutide holds promise for substantial weight reduction in adults with obesity over a 48-week period
Data show that up to two-thirds of patients with HFpEF have CAD or coronary microvascular dysfunction including ischaemia, which leads to disruption of LV diastolic and systolic function, development of fibrosis, increased myocardial stiffness and cardiac remodelling
With Ozempic being the well-known FDA-approved brand and compounded alternatives becoming available, patients often wonder which option offers the best balance of safety, effectiveness, and affordability for their specific health needs
